skip navigation


Home » Resources » Clinical Studies » Temporal Variation in Optical Coherence Tomography Measurements of Retinal Thickening in Diabetic Macular Edema

Clinical Studies Supported by the NEI

Temporal Variation in Optical Coherence Tomography Measurements of Retinal Thickening in Diabetic Macular Edema

Purpose | Background | Description | Patient Eligibility | Patient Recruitment Status | Current Status of Study | Results | Publications | Clinical Centers | NEI Representative | Resource Centers

Purpose:

A one day study designed to assess the variability of retinal thickening and OCT measurements throughout the day.

Background:

Optical Coherence Tomography (OCT) is a noninvasive method for measuring the thickness of the central retina. It has become a standard tool in the management of patients with diabetic macular edema (DME).

OCT is a diagnostic imaging technique, which uses low-coherence interferometry to produce cross-sectional tomograms of the posterior segment eye structures. An 850 nm light source emits a probe beam of infrared light, which is split between the eye and a reference mirror at a known spatial location therefore producing two beams. Both beams are reflected back to a photo detector, the time of flight delay of light back scattered from different layers in the retina is determined, and thickness data are obtained. The OCT's internal computer acquires and processes the data to produce enhanced images. Retinal thickness is determined using many individual A-scans along each of six B-Scans. A computer algorithm is used to determine the inner and outer retinal boundaries for each scan.

The variability of retinal thickening during the day and the variability of OCT measurements in the study of macular edema is an area of considerable interest. A study by Frank et al indicated that OCT retinal thickness measurements in DME vary according to time of day. In that study of 10 subjects, retinal thickness was measured at 8:00 am, 11:00 am, 2:00 pm, and 5:00 pm. There was a decline in the average macular thickness from 8:00 to 11:00 am and relatively little change thereafter. Only four of the 10 subjects had a consistent decrease in the thickening over the course of the day. The eyes with greater retinal thickening tended to show a greater decline over the day than did the eyes with less thickening. The magnitude of the decrease in retinal thickening appeared to be relatively small, although statistically significant. An earlier study by Sternberg et al that employed psychovisual assessments noted that visual function due to macular edema may vary with time of day, generally worse in the morning, which supports the anatomic observations in the study by Frank, et al.

Since OCT is being used as an outcome measure in DME studies, it is important to have more information on its reproducibility as well as more information on the effect of the time of day on retinal thickening.

Description:

This study is one of a series of studies being conducted by the Diabetic Retinopathy Clinical Research Network. The study will enroll approximately 100 subjects with DME in at least one eye at participating sites. Subjects will be selected so that there will be approximately 33 eyes with DME in the range of 225 to 300 microns (measured from the center subfield of the OCT3 retina map), 33 in the range of 300 to 450 microns, and 33 with >450 microns. Each subject will have two OCT measurements made on each eye every two hours from 8 am to 4 pm, with an additional measurement at 9 am. Measurements will be made by the same operator using the same OCT3 machine at each time point. The second measurement at each time point may be made by the same or a different operator. Two consecutive fast macular scans of acceptable quality will be submitted (center point thickness with standard deviation less than 10%).

Patient Eligibility:

Inclusion Criteria

  1. Diagnosis of diabetes mellitus (type 1 or type 2). Any one of the following will be considered sufficient evidence that diabetes is present:
    -Current regular use of insulin for the treatment of diabetes
    -Current regular use of oral antihyperglycemia agents for the treatment of diabetes
    -Documented diabetes by ADA and/or WHO criteria (see Site Coordinator Manual)
  2. In at least one eye: (1) definite retinal thickening due to diabetic macular edema based on clinical exam involving the center of the macula, (2) OCT central subfield >=225 microns, and (3) pupil dilates to 5 mm or larger.
  3. Able and willing to provide informed consent.

Exclusion Criteria

  1. History of chronic renal failure requiring dialysis or kidney transplant.
  2. Congestive heart failure currently under treatment.
  3. Blood pressure >180/110 (systolic above 180 OR diastolic above 110).

Patient Recruitment Status:

No longer recruiting. Comments: Recruitment has ended.

Current Status of Study:

Completed, with results published. Comments:

Results:

The objective of this study was to evaluate diurnal variation in retinal thickness measured with optical coherence tomography (OCT) in patients with center-involved diabetic macular edema. OCT measurements were performed 6 times in a single day between 8 am and 4 pm in 156 eyes of 96 subjects. At 8 am, the average central subfield thickness was 368 microns and the mean visual acuity was approximately 20/50. On average, the change in relative central subfield retinal thickening between 8 am and 4 pm was a decrease of 6% (95% confidence interval, -9% to -3%) and the mean absolute change was a decrease of 13 microns (95% CI, -17 to -8). The absolute change was greater in retinas that were thicker at 8 am (P<.001) but the relative change was not (P = .14). Five eyes of 4 subjects decreased in central subfield thickening by at least 25% and 50 microns at two consecutive time points. Two eyes of 2 subjects had an increase of this same magnitude. The maximum decrease was observed at 4 pm in all 5 eyes. Although throughout the day there are slight decreases on average in retinal thickening, most eyes with diabetic macular edema have little meaningful change in OCT central subfield thickening between 8 am and 4 pm.

Publications

Diabetic Retinopathy Clinical Research Network: Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema.  Ophthalmology  114: 1520-5, 2007  

Diabetic Retinopathy Clinical Research Network: Diurnal Variation in Retinal Thickening Measurement by OCT in Center-involved Diabetic Macular Edema .  Arch Ophthalmol  124: 1701-1707, 2006  


Clinical Centers


Colorado
Antonio P. Ciardella, M.D.
Denver Health Medical Center
777 Bannock Street, Mail Code 0156
Denver, CO 80204

Florida
Don John Perez Ortiz, M.D.
International Eye Center
4506 Wishart Place
Tampa, FL 33603

Florida
Keye L. Wong, M.D.
Sarasota Retina Institute
3400 Bee Ridge Road
Suite 200
Sarasota, FL 34239

Florida
Preston P. Richmond, M.D.
Central Florida Retina
330 Waymont Court
Lake Mary, FL 32746

Florida
Scott M. Friedman, M.D.
Central Florida Retina Institute
2202 Lakeland Hills Blvd
Lakeland, FL 33805

Illinois
Alice T. Lyon, M.D.
Northwestern Medical Faculty Foundation
Department Of Ophthalmology
675 N St. Clair Suite 15-150
Chicago, IL 60611

Kentucky
Carl W. Baker, M.D.
Paducah Retinal Center
1900 Broadway
Suite 2
Paducah, KY 42001

Massachusetts
George S. Sharuk, M.D.
Joslin Diabetes Center
Beetham Eye Institute
One Joslin Place
Boston, MA 02215

Massachusetts
Trexler M. Topping, M.D.
Ophthalmic Consultants of Boston
50 Staniford Street
Suite 600
Boston, MA 02114

New York
G. Robert Hampton, M.D.
Retina-Vitreous Surgeons of Central New York, PC
3107 E. Genesee Street
Syracuse, NY 13224

New York
Paul M. Beer, M.D.
Lions Eye Institute
Retina Consultants, PLLC
1220 New Scotland Road
Suite 201
Slingerlands, NY 12159

North Carolina
David Browning, M.D.
Charlotte Eye, Ear, Nose and Throat Assoc., PA
6035 Fairview Road
Charlotte, NC 28210

Ohio
Frederick H. Davidorf, M.D.
Retinal Consultants, Inc.
6805 Avery-Muirfield Dr. #100
Dublin, OH 43017

Oregon
Mark A. Peters, M.D.
Retina Northwest, PC
2525 NW Lovejoy
Suite 300
Portland, OR 97210

Rhode Island
Magdalena G. Krzystolik, M.D.
Retina Consultants
690 Eddy Street
Providence, RI 02903

South Carolina
Jeffrey G. Gross, M.D.
Carolina Retina Center
7620 Trenholm Road Extension
Columbia, SC 29223

South Carolina
W. Lloyd Clark, M.D.
Palmetto Retina Center
2750 Laurel Street
Suite 101
Columbia, SC 29204

Tennessee
Franco M. Recchia, M.D.
Vanderbilt University Medical Center
8000 Medical Center East
Nashville, TN 37232

Texas
Brian B. Berger, M.D.
Retina Research Center
3705 Medical Parkway
Suite 410
Austin, TX 78705

Texas
David M. Brown, M.D., F.A.C.S.
Vitreoretinal Consultants
6560 Fannin
Suite 750
Houston, TX 77030

Texas
Gary E. Fish, M.D.
Texas Retina Associates
7150 Greenville Avenue
Suite 400
Dallas, TX 75231

Texas
Michel Shami, M.D.
Texas Retina Associates
3802 22nd Street
Suite B
Lubbock, TX 79410

Texas
Victor H. Gonzalez, M.D.
Valley Retina Institute
1309 E. Ridge Rd.
Suite 1
McAllen, TX 78503

Washington
James L. Kinyoun, M.D.
University of Washington Medical Center
Room NN300, Eye Clinic
1959 NE Pacific Street
Seattle, WA 98195

Wisconsin
Judy E. Kim, M.D.
Medical College of Wisconsin
925 N 87th Street
Milwaukee, WI 53226

NEI Representative



National Eye Institute
National Institutes of Health
Suite 1300
5635 Fishers Lane MSC 9300
Bethesda, MD 20892-9300
USA
Telephone: (301) 451-2020
Fax: (301) 402-0528

Resource Centers


Coordinating Center
Roy W. Beck, M.D., Ph.D.
Jaeb Center for Health Research
15310 Amberly Drive, Suite 350
Tampa, FL 33647
USA
Telephone: (813) 975-8690
Fax: (813) 975-8761
Email: rbeck@jaeb.org

Fundus Photograph Reading Center
Matthew D. Davis, M.D.
University of Wisconsin-Madison
Department of Ophthalmology and Visual Sciences
Park West One
406 Science Drive, Suite 400
Madison, WI 53711
USA
Telephone: (608) 263-4538
Fax: (608) 263-0525
Email: davis@rc.ophth.wisc.edu

Network Chairman's Office
Lloyd P. Aiello, M.D., Ph.D.
Joslin Diabetes Center
One Joslin Place
Boston, MA 02215
USA
Telephone: (617) 732-2535
Fax: (617) 264-2776
Email: lpaiello@joslin.harvard.edu

Last Updated: 9/4/2008

 

Bookmark or share this page


U. S. Department of Health and Human Services

National Institutes of Health

USA.gov